Agilent Technologies (NYSE: A) and Edap Tms (NASDAQ:EDAP) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.
Risk and Volatility
Agilent Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.
This is a breakdown of current ratings and price targets for Agilent Technologies and Edap Tms, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Agilent Technologies presently has a consensus price target of $69.23, suggesting a potential upside of 5.16%. Edap Tms has a consensus price target of $6.50, suggesting a potential upside of 122.60%. Given Edap Tms’ stronger consensus rating and higher probable upside, analysts plainly believe Edap Tms is more favorable than Agilent Technologies.
Agilent Technologies pays an annual dividend of $0.53 per share and has a dividend yield of 0.8%. Edap Tms does not pay a dividend. Agilent Technologies pays out 25.2% of its earnings in the form of a dividend.
Insider & Institutional Ownership
10.5% of Edap Tms shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Agilent Technologies and Edap Tms’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Agilent Technologies||$4.47 billion||4.74||$684.00 million||$2.10||31.35|
|Edap Tms||$39.28 million||2.16||$4.25 million||($0.08)||-36.50|
Agilent Technologies has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.
This table compares Agilent Technologies and Edap Tms’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Agilent Technologies beats Edap Tms on 10 of the 15 factors compared between the two stocks.
Agilent Technologies Company Profile
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Edap Tms Company Profile
EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.